Onyx Pharmaceuticals, Inc

Posted On Sep 16 2016 by

#onyx pharma # Welcome to the Onyx Pharmaceuticals, Inc. Shareholder Litigation Website This website has been established to provide general information regarding the Onyx Pharmaceuticals, Inc.(“Onyx”) Shareholder Litigation, pending in the Superior Court of California, County of San Mateo (the “Court”). The capitalized terms used on this website and not defined herein shall have the same meanings ascribed to them in the Order Granting Class Certification dated April 10, 2015. If you were a holder of Onyx common stock who received consideration for their shares in the Acquisition of Onyx by Amgen at the price of $125.00 per share who …


Pharmaceuticals jobs

Posted On Sep 16 2016 by

#pharmaceuticals jobs # 278BioTech / Pharmaceuticalindustry jobs West Login to view salary Responsibilities: Provide support for finance activities: closing, balance sheet. Responsible to maintain and reconcile general ledger. Review and perform monthly amortization of prepayment on monthly basis prior to month-end close. Assist in preparation of statutory and taxation schedules and. Associate Engineer (MNC / Pharmaceutical / East / 5D / Up $3.5k / GMP / Gxp Doc / ) East (Singapore) Login to view salary Our Clients A fast growing and leading pharmaceutical company of high establishment is undergoing expansion plans in the region to support the. West Login …


Pharmaceuticals – Bayer Australia and New Zealand

Posted On Sep 15 2016 by

#bayer schering pharma # Pharmaceuticals Bayer’s Pharmaceuticals division is a significant player in the pharmaceutical industry, globally and here in Australia and New Zealand. The product portfolio lies across major business units of Women s Healthcare, General Medicine, Specialty Medicine and Diagnostic Imaging. Using new ideas, Pharmaceuticals aims to make a contribution to medical progress and strives to improve the quality of life. For further information about Pharmaceuticals visit pharma.bayer.com/ This page contains approved Product Information (PI) and Consumer Medicine Information (CMI) for Pharmaceuticals products in Australia. Product Information is intended to assist healthcare professionals make decisions about treatment options …


Pharmaceuticals – UK – Bayer plc

Posted On Sep 15 2016 by

#bayer schering pharma # About Us Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2014, the Group employed around 119,000 people and had sales of EUR 42.2 billion. Capital expenditures amounted to EUR 2.5 billion, R …


Bayer HealthCare Pharmaceuticals Inc

Posted On Sep 15 2016 by

#bayer schering pharma # Bayer HealthCare Pharmaceuticals Inc. Latest Drug Information Updates Troxyca ER Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) is an extended-release, abuse-deterrent. Adlyxin Adlyxin (lixisenatide) is a once-daily prandial glucagon-like peptide-1 (GLP-1) receptor agonist indicated. Xiidra Xiidra (lifitegrast) is a lymphocyte function-associated antigen-1 (LFA-1) antagonist indicated for the. Epclusa Epclusa (sofosbuvir and velpatasvir) is a nucleotide analog polymerase inhibitor and pan-genotypic NS5A. Byvalson Byvalson (nebivolol and valsartan) is a beta adrenergic blocker and an angiotensin II receptor blocker (ARB). Zinbryta Zinbryta (daclizumab) is an interleukin-2 receptor blocking antibody indicated for the treatment of relapsing. More. Was this …


Sun Pharmaceuticals to sell some low priority Ranbaxy brands – The Economic Times

Posted On Sep 15 2016 by

#sun pharma products # Sun Pharmaceuticals to sell some low priority Ranbaxy brands MUMBAI: Drug maker Sun Pharmaceuticals has put on the block a bundle of Ranbaxy brands which are low priority in its domestic market strategy or which may overlap with its own products, top industry executives said. The country’s largest drug maker completed acquisition of Ranbaxy last year from its Japanese owner, Daiichi Sankyo. as part of a $4 billion all-stock deal. The Ranbaxy brands that Sun is looking to sell rake in about Rs 115 crore in annual sales and the company is expecting a valuation of …


Boehringer pharmaceuticals

Posted On Sep 15 2016 by

#boehringer pharmaceuticals # История В двух словах Value Through Innovation. The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally with 145 affiliates and a total of around 47,500 employees. The focus of the family-owned company, founded in 1885, is researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine. Social responsibility is an important element of the corporate culture at Boehringer Ingelheim. This includes worldwide involvement in social projects, such as the initiative “Making more Health” and caring for the employees. Respect, …